Genomind Launches the Most Comprehensive Genetics-Based Mental Health Test Available, Genomind Professional PGx, to Help Clinicians Optimize Mental Health Medication Decisions – Business Wire
Genomind Launches the Most Comprehensive Genetics-Based Mental Health Test Available, Genomind Professional PGx, to Help Clinicians Optimize Mental Health Medication Decisions Business Wire
Genomind – a leading mental health care company – today announced that its flagship pharmacogenetic product, Genomind Professional PGx™, is now availa.
Posted on Monday, May 20th, 2019 at 5:30 am. Filed under: News Feeds RSS 2.0 feed.
Leave a Reply
You must be logged in to post a comment.